Findings seen over three months in men with low-grade prostate cancer, hypogonadism treated with radical prostatectomy.

Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.

Long-term follow-up consistent with earlier report, a hint of benefit in high-grade diseas ...

Stereotactic body radiotherapy as salvage therapy after radical prostatectomy was well tolerated. Toxic effects were comparable to a historical cohort of patients receiving conventionally fractionated ...

Investigators conducted a meta-analysis of 4 randomized controlled trials including a total of more than 1000 men with prostate cancer.

Soputro delivered a podium presentation comparing outcomes between transvesical (TV) and extraperitoneal (EP) approaches for single-port robotic-assisted radical prostatectomy (SP-RARP). As ...

From 2004-2009 to 2016-2020, the proportion of patients found to have high-risk and intermediate-risk prostate cancer after upfront radical prostatectomy increased from 16% to 27% and from 55% to 60%, ...

Surgery reduced the risk of cancer death among men with de novo oligometastatic prostate cancer receiving systemic therapy. The addition of radical prostatectomy (RP) to best initial systemic therapy ...

Also previously reported, there was no benefit for extended pelvic lymphadenectomy in the overall cohort for metastasis free ...

A new podcast fronted by writer, comedian and broadcaster Jon Holmes is aiming to help men better understand their prostate cancer treatment options ...